38 related articles for article (PubMed ID: 26206946)
1. STRATEGIES FOR EQUITABLE PHARMACOGENOMIC-GUIDED WARFARIN DOSING AMONG EUROPEAN AND AFRICAN AMERICAN INDIVIDUALS IN A CLINICAL POPULATION.
Wiley LK; Vanhouten JP; Samuels DC; Aldrich MC; Roden DM; Peterson JF; Denny JC
Pac Symp Biocomput; 2017; 22():545-556. PubMed ID: 27897005
[TBL] [Abstract][Full Text] [Related]
2. Local Ancestry-Informed Candidate Pathway Analysis of Warfarin Stable Dose in Latino Populations.
Steiner HE; Carrion KC; Giles JB; Lima AR; Yee K; Sun X; Cavallari LH; Perera MA; Duconge J; Karnes JH
Clin Pharmacol Ther; 2023 Mar; 113(3):680-691. PubMed ID: 36321873
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Nine Statistical Model Based Warfarin Pharmacogenetic Dosing Algorithms Using the Racially Diverse International Warfarin Pharmacogenetic Consortium Cohort Database.
Liu R; Li X; Zhang W; Zhou HH
PLoS One; 2015; 10(8):e0135784. PubMed ID: 26305568
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenomic Testing and Warfarin Management.
Maluso A
Oncol Nurs Forum; 2015 Sep; 42(5):563-5. PubMed ID: 26302287
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacogenetic algorithms for predicting the appropriate dose of vitamin K antagonists: are they still useful?].
Mundi S; Distante A; De Caterina R
G Ital Cardiol (Rome); 2014 Oct; 15(10):546-60. PubMed ID: 25424019
[TBL] [Abstract][Full Text] [Related]
6. Optimal dosing of warfarin and other coumarin anticoagulants: the role of genetic polymorphisms.
Daly AK
Arch Toxicol; 2013 Mar; 87(3):407-20. PubMed ID: 23376975
[TBL] [Abstract][Full Text] [Related]
7. Warfarin pharmacogenomics and African ancestry.
Price ET
Blood; 2015 Jul; 126(4):434-6. PubMed ID: 26206946
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics of Warfarin Therapy.
Ruff CT
Clin Chem; 2018 Nov; 64(11):1558-1559. PubMed ID: 29941467
[No Abstract] [Full Text] [Related]
9. Validating two international warfarin pharmacogenetic dosing algorithms for estimating the maintenance dose for patients in Singapore.
Soh SPY; See Toh WY; Ten WQ; Leong KP; Goh LL
Ann Acad Med Singap; 2024 Mar; 53(3):208-210. PubMed ID: 38920246
[No Abstract] [Full Text] [Related]
10. What is the role of pharmacogenetics in optimization of warfarin dosing?
Carnes CA
Trends Cardiovasc Med; 2015 Jan; 25(1):42-3. PubMed ID: 25476743
[No Abstract] [Full Text] [Related]
11. Implementing Algorithm-Guided Warfarin Dosing in an Ethnically Diverse Patient Population Using Electronic Health Records and Preemptive CYP2C9 and VKORC1 Genetic Testing.
Obeng AO; Kaszemacher T; Abul-Husn NS; Gottesman O; Vega A; Waite E; Myers K; Cho J; Bottinger EP; Ellis SB; Scott SA
Clin Pharmacol Ther; 2016 Nov; 100(5):427-430. PubMed ID: 27393744
[TBL] [Abstract][Full Text] [Related]
12. Race influences warfarin dose changes associated with genetic factors.
Limdi NA; Brown TM; Yan Q; Thigpen JL; Shendre A; Liu N; Hill CE; Arnett DK; Beasley TM
Blood; 2015 Jul; 126(4):539-45. PubMed ID: 26024874
[TBL] [Abstract][Full Text] [Related]
13. Poor warfarin dose prediction with pharmacogenetic algorithms that exclude genotypes important for African Americans.
Drozda K; Wong S; Patel SR; Bress AP; Nutescu EA; Kittles RA; Cavallari LH
Pharmacogenet Genomics; 2015 Feb; 25(2):73-81. PubMed ID: 25461246
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
